Monahan M, et al. - Using a Markov patient-level simulation model, researchers evaluated the cost-effectiveness of physician titration of antihypertensive medication using self-monitored blood pressure, with or without telemonitoring, for hypertension treatment decisions in primary care vs usual care. In probabilistic sensitivity analysis, they found that, relative to usual care, self-monitoring irrespective of transmission modality was likely to be cost-effective (89% probability of cost-effectiveness at £20 000/quality-adjusted life year); however, there was high uncertainty about the most cost-effective option between telemonitoring or self-monitoring alone. In clinical practice, self-monitoring appeared cost-effective and likely to result in attenuated cardiovascular mortality and morbidity.